Facial  	Facial  	 JJ	O
rejuvenation  	rejuvenation  	 NN	O
after  	after  	 IN	O
intradermal  	intradermal  	 JJ	B-NP
botulinum  	botulinum  	 JJ	I-NP
toxin 	toxin 	 NN	I-NP
:  	:  	 :	O
is  	is  	 VBZ	O
it  	it  	 PRP	O
really  	really  	 RB	O
the  	the  	 DT	O
botulinum  	botulinum  	 JJ	B-NP
toxin  	toxin  	 NN	I-NP
or  	or  	 CC	O
is  	is  	 VBZ	O
it  	it  	 PRP	O
the  	the  	 DT	O
pricks 	pricks 	 NN	O
?  	?  	 .	O
The  	The  	 DT	O
use  	use  	 NN	O
of  	of  	 IN	O
intradermal  	intradermal  	 JJ	B-NP
botulinum  	botulinum  	 JJ	I-NP
toxin  	toxin  	 NN	I-NP
A  	A  	 DT	O
( 	( 	 -LRB-	O
onabotulinumtoxinA 	onabotulinumtoxinA 	 NNP	B-NP
)  	)  	 -RRB-	O
remains  	remains  	 VBZ	O
a  	a  	 DT	O
relatively  	relatively  	 RB	O
new  	new  	 JJ	O
technique  	technique  	 NN	O
and  	and  	 CC	O
is  	is  	 VBZ	O
an  	an  	 DT	O
off-label  	off-label  	 JJ	B-NP
cosmetic  	cosmetic  	 JJ	I-NP
application  	application  	 NN	I-NP
for  	for  	 IN	O
facial  	facial  	 JJ	B-NP
skin  	skin  	 NN	I-NP
rejuvenation 	rejuvenation 	 NN	I-NP
.  	.  	 .	O
There  	There  	 EX	O
is  	is  	 VBZ	O
little  	little  	 RB	O
documented  	documented  	 VBN	O
clinical  	clinical  	 JJ	B-NP
evidence  	evidence  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
objective  	objective  	 JJ	I-NP
benefits  	benefits  	 NNS	I-NP
of  	of  	 IN	O
this  	this  	 DT	O
therapy 	therapy 	 NN	O
.  	.  	 .	O
To  	To  	 TO	O
determine  	determine  	 VB	O
whether  	whether  	 IN	O
intradermal  	intradermal  	 JJ	B-NP
facial  	facial  	 JJ	I-NP
onabotulinumtoxinA  	onabotulinumtoxinA  	 JJ	I-NP
injection  	injection  	 NN	I-NP
has  	has  	 VBZ	O
any  	any  	 DT	O
benefits 	benefits 	 NNS	O
.  	.  	 .	O
Interventional 	Interventional 	 NNP	B-NP
,  	,  	 ,	O
comparative 	comparative 	 JJ	O
,  	,  	 ,	O
split  	split  	 NN	B-NP
face  	face  	 NN	I-NP
clinical  	clinical  	 JJ	I-NP
trial 	trial 	 NN	I-NP
.  	.  	 .	O
Informed  	Informed  	 JJ	B-NP
consent  	consent  	 NN	I-NP
was  	was  	 VBD	O
obtained  	obtained  	 VBN	O
from  	from  	 IN	O
10  	10  	 CD	O
physicians 	physicians 	 NNS	O
.  	.  	 .	O
One  	One  	 CD	O
half  	half  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
physician 	physician 	 NN	O
's  	's  	 POS	O
faces  	faces  	 NNS	O
were  	were  	 VBD	O
randomly  	randomly  	 RB	O
injected  	injected  	 VBN	O
with  	with  	 IN	O
onabotulinumtoxinA  	onabotulinumtoxinA  	 NNP	B-NP
( 	( 	 -LRB-	O
2  	2  	 CD	O
U 	U 	 NNP	O
/ 	/ 	 CD	O
0.1  	0.1  	 CD	O
mL 	mL 	 NN	O
;  	;  	 :	O
30  	30  	 CD	O
facial  	facial  	 JJ	B-NP
injections  	injections  	 NNS	I-NP
on  	on  	 IN	O
half  	half  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
face 	face 	 NN	O
,  	,  	 ,	O
each  	each  	 DT	O
0.1  	0.1  	 CD	O
mL 	mL 	 NN	O
)  	)  	 -RRB-	O
intradermally  	intradermally  	 NN	O
and  	and  	 CC	O
the  	the  	 DT	O
other  	other  	 JJ	O
half  	half  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
face  	face  	 NN	O
with  	with  	 IN	O
normal  	normal  	 JJ	B-NP
saline  	saline  	 NNS	I-NP
( 	( 	 -LRB-	O
30  	30  	 CD	O
facial  	facial  	 JJ	B-NP
injections  	injections  	 NNS	I-NP
on  	on  	 IN	O
half  	half  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
face 	face 	 NN	O
,  	,  	 ,	O
each  	each  	 DT	O
0.1  	0.1  	 CD	O
mL 	mL 	 NN	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
injecting  	injecting  	 JJ	O
clinician  	clinician  	 NN	B-NP
and  	and  	 CC	O
the  	the  	 DT	O
subjects  	subjects  	 NNS	B-NP
were  	were  	 VBD	O
blinded  	blinded  	 VBN	O
to  	to  	 TO	O
the  	the  	 DT	O
contents  	contents  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
syringes 	syringes 	 NN	O
.  	.  	 .	O
One  	One  	 CD	O
and  	and  	 CC	O
4  	4  	 CD	O
weeks  	weeks  	 NNS	O
later 	later 	 RB	O
,  	,  	 ,	O
two  	two  	 CD	O
neutral 	neutral 	 JJ	O
,  	,  	 ,	O
blinded  	blinded  	 JJ	O
observers  	observers  	 NNS	O
assessed  	assessed  	 VBD	O
the  	the  	 DT	O
subjects  	subjects  	 NNS	B-NP
in  	in  	 IN	O
person 	person 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
patients  	patients  	 NNS	O
were  	were  	 VBD	O
also  	also  	 RB	O
photographed  	photographed  	 VBN	O
in  	in  	 IN	O
ambient  	ambient  	 JJ	O
light  	light  	 JJ	O
surroundings  	surroundings  	 NN	O
and  	and  	 CC	O
the  	the  	 DT	O
same  	same  	 JJ	O
observers  	observers  	 NNS	O
compared  	compared  	 VBN	O
the  	the  	 DT	O
halves  	halves  	 NN	O
of  	of  	 IN	O
their  	their  	 PRP$	O
faces  	faces  	 NNS	O
in  	in  	 IN	O
photographs  	photographs  	 NNS	O
and  	and  	 CC	O
rated  	rated  	 VBN	O
them  	them  	 PRP	O
on  	on  	 IN	O
a  	a  	 DT	O
scale  	scale  	 NN	O
of  	of  	 IN	O
-4  	-4  	 CD	O
to  	to  	 TO	O
+4 	+4 	 CD	O
.  	.  	 .	O
Global  	Global  	 JJ	B-NP
improvement  	improvement  	 NN	I-NP
in  	in  	 IN	O
skin  	skin  	 NN	O
texture  	texture  	 NN	O
and  	and  	 CC	O
tightness  	tightness  	 NN	O
was  	was  	 VBD	O
noted  	noted  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
post-treatment  	post-treatment  	 JJ	B-NP
photographs  	photographs  	 NNS	I-NP
( 	( 	 -LRB-	O
the  	the  	 DT	O
skin  	skin  	 NN	O
appeared  	appeared  	 VBD	O
to  	to  	 TO	O
be  	be  	 VB	O
tenser  	tenser  	 NNS	O
and  	and  	 CC	O
smoother 	smoother 	 JJR	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
although  	although  	 IN	O
there  	there  	 EX	O
was  	was  	 VBD	O
no  	no  	 DT	O
difference  	difference  	 NN	O
between  	between  	 IN	O
the  	the  	 DT	O
two  	two  	 CD	O
groups  	groups  	 NNS	O
and 	and 	 CC	O
,  	,  	 ,	O
hence 	hence 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
changes  	changes  	 NNS	O
could  	could  	 MD	O
not  	not  	 RB	O
be  	be  	 VB	O
clinically  	clinically  	 RB	O
ascribed  	ascribed  	 VBN	O
to  	to  	 TO	O
the  	the  	 DT	O
intradermal  	intradermal  	 JJ	B-NP
botulinum  	botulinum  	 JJ	I-NP
toxin  	toxin  	 NN	I-NP
injections 	injections 	 NNS	I-NP
.  	.  	 .	O
No  	No  	 DT	O
other  	other  	 JJ	O
meaningful  	meaningful  	 JJ	O
clinical  	clinical  	 JJ	B-NP
difference  	difference  	 NN	I-NP
could  	could  	 MD	O
be  	be  	 VB	O
demonstrated  	demonstrated  	 VBN	O
between  	between  	 IN	O
the  	the  	 DT	O
two  	two  	 CD	O
sides  	sides  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
face 	face 	 NN	O
,  	,  	 ,	O
in  	in  	 IN	O
any  	any  	 DT	O
of  	of  	 IN	O
the  	the  	 DT	O
10  	10  	 CD	O
subjects 	subjects 	 NNS	B-NP
,  	,  	 ,	O
in  	in  	 IN	O
person  	person  	 NN	O
or  	or  	 CC	O
in  	in  	 IN	O
photographs 	photographs 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
small  	small  	 JJ	O
study  	study  	 NN	B-NP
sample  	sample  	 NN	I-NP
precluded  	precluded  	 VBN	O
formal  	formal  	 JJ	B-NP
statistical  	statistical  	 JJ	I-NP
analysis 	analysis 	 NN	I-NP
.  	.  	 .	O
Intradermal  	Intradermal  	 JJ	B-NP
botulinum  	botulinum  	 JJ	I-NP
toxin  	toxin  	 NN	I-NP
A  	A  	 DT	O
injection  	injection  	 NN	B-NP
does  	does  	 VBZ	O
not  	not  	 RB	O
appear  	appear  	 VB	O
to  	to  	 TO	O
have  	have  	 VB	O
any  	any  	 DT	O
benefit  	benefit  	 NN	O
in  	in  	 IN	O
facial  	facial  	 JJ	B-NP
rejuvenation 	rejuvenation 	 NN	I-NP
.  	.  	 .	O
